1. Home
  2. IRON vs HWKN Comparison

IRON vs HWKN Comparison

Compare IRON & HWKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRON
  • HWKN
  • Stock Information
  • Founded
  • IRON 2017
  • HWKN 1938
  • Country
  • IRON United States
  • HWKN United States
  • Employees
  • IRON N/A
  • HWKN N/A
  • Industry
  • IRON Biotechnology: Pharmaceutical Preparations
  • HWKN Specialty Chemicals
  • Sector
  • IRON Health Care
  • HWKN Consumer Discretionary
  • Exchange
  • IRON Nasdaq
  • HWKN Nasdaq
  • Market Cap
  • IRON 1.9B
  • HWKN 2.2B
  • IPO Year
  • IRON N/A
  • HWKN N/A
  • Fundamental
  • Price
  • IRON $52.23
  • HWKN $106.12
  • Analyst Decision
  • IRON Strong Buy
  • HWKN Hold
  • Analyst Count
  • IRON 10
  • HWKN 1
  • Target Price
  • IRON $83.80
  • HWKN $122.00
  • AVG Volume (30 Days)
  • IRON 342.1K
  • HWKN 108.2K
  • Earning Date
  • IRON 05-08-2025
  • HWKN 05-14-2025
  • Dividend Yield
  • IRON N/A
  • HWKN 0.68%
  • EPS Growth
  • IRON N/A
  • HWKN 12.32
  • EPS
  • IRON N/A
  • HWKN 3.91
  • Revenue
  • IRON N/A
  • HWKN $952,133,000.00
  • Revenue This Year
  • IRON N/A
  • HWKN $6.21
  • Revenue Next Year
  • IRON N/A
  • HWKN $5.81
  • P/E Ratio
  • IRON N/A
  • HWKN $27.27
  • Revenue Growth
  • IRON N/A
  • HWKN 3.01
  • 52 Week Low
  • IRON $25.60
  • HWKN $71.98
  • 52 Week High
  • IRON $68.73
  • HWKN $139.55
  • Technical
  • Relative Strength Index (RSI)
  • IRON 44.88
  • HWKN 49.47
  • Support Level
  • IRON $51.57
  • HWKN $105.71
  • Resistance Level
  • IRON $53.61
  • HWKN $108.91
  • Average True Range (ATR)
  • IRON 2.00
  • HWKN 2.82
  • MACD
  • IRON 0.06
  • HWKN 0.50
  • Stochastic Oscillator
  • IRON 36.43
  • HWKN 57.95

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers.

Share on Social Networks: